Company · CIK 1802369

# ADARx Pharmaceuticals, Inc.

| CIK | [1802369](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001802369) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | ADRX (Nasdaq) |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-298782 | IPO Final prospectus | 2026-09-04 | 2026-09-28 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-28 | [424B4](https://www.sec.gov/Archives/edgar/data/1802369/000119312526403094/0001193125-26-403094-index.htm) Final prospectus | 333-298782 | 0001193125-26-403094 |
| 2026-09-24 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1802369/999999999526003052/9999999995-26-003052-index.htm) Declared effective | 333-298782 | 9999999995-26-003052 |
| 2026-09-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1802369/000119312526396007/0001193125-26-396007-index.htm) Amendment | 333-298782 | 0001193125-26-396007 |
| 2026-09-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1802369/000119312526390724/0001193125-26-390724-index.htm) Amendment | 333-298782 | 0001193125-26-390724 |
| 2026-09-04 | [S-1](https://www.sec.gov/Archives/edgar/data/1802369/000119312526383838/0001193125-26-383838-index.htm) Registration filed | 333-298782 | 0001193125-26-383838 |
| 2026-06-22 | [DRS](https://www.sec.gov/Archives/edgar/data/1802369/000119312526277710/0001193125-26-277710-index.htm) Draft made public | 377-09495 | 0001193125-26-277710 |

[All filings of this company](https://equitycapital.markets/filings?cik=1802369) · [CSV](https://equitycapital.markets/filings.csv?cik=1802369)

---
Source page: https://equitycapital.markets/company/1802369 · Data: U.S. SEC EDGAR · CC BY 4.0